Literature DB >> 16938098

CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding.

Julien Marquis1, Luc Paillard, Yann Audic, Bertrand Cosson, Olivier Danos, Christine Le Bec, H Beverley Osborne.   

Abstract

CUG-BP1 [CUG-binding protein 1 also called CELF (CUG-BP1 and ETR3 like factors) 1] is a human RNA-binding protein that has been implicated in the control of splicing and mRNA translation. The Xenopus homologue [EDEN-BP (embryo deadenylation element-binding protein)] is required for rapid deadenylation of certain maternal mRNAs just after fertilization. A variety of sequence elements have been described as target sites for these two proteins but their binding specificity is still controversial. Using a SELEX (systematic evolution of ligand by exponential enrichment) procedure and recombinant CUG-BP1 we selected two families of aptamers. Surface plasmon resonance and electrophoretic mobility-shift assays showed that these two families differed in their ability to bind CUG-BP1. Furthermore, the selected high-affinity aptamers form two complexes with CUG-BP1 in electrophoretic mobility assays whereas those that bind with low affinity only form one complex. The validity of the distinction between the two families of aptamers was confirmed by a functional in vivo deadenylation assay. Only those aptamers that bound CUG-BP1 with high affinity conferred deadenylation on a reporter mRNA. These high-affinity RNAs are characterized by a richness in UGU motifs. Using these binding site characteristics we identified the Xenopus maternal mRNA encoding the MAPK (mitogen-activated protein kinase) phosphatase (XCl100alpha) as a substrate for EDEN-BP. In conclusion, high-affinity CUG-BP1 binding sites are sequence elements at least 30 nucleotides in length that are enriched in combinations of U and G nucleotides and contain at least 4 UGU trinucleotide motifs. Such sequence elements are functionally competent to target an RNA for deadenylation in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938098      PMCID: PMC1652823          DOI: 10.1042/BJ20060490

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Biosensor analysis of drug-target interactions: direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors.

Authors:  R Karlsson; M Kullman-Magnusson; M D Hämäläinen; A Remaeus; K Andersson; P Borg; E Gyzander; J Deinum
Journal:  Anal Biochem       Date:  2000-02-01       Impact factor: 3.365

2.  A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex.

Authors:  C Grosset; C Y Chen; N Xu; N Sonenberg; H Jacquemin-Sablon; A B Shyu
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

3.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors.

Authors: 
Journal:  Curr Opin Biotechnol       Date:  1997-02-01       Impact factor: 9.740

4.  Changes in the polyadenylation of specific stable RNA during the early development of Xenopus laevis.

Authors:  J Paris; H B Osborne; A Couturier; R Le Guellec; M Philippe
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

5.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.

Authors:  N A Timchenko; A L Welm; X Lu; L T Timchenko
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

Review 6.  Diversity of oligonucleotide functions.

Authors:  L Gold; B Polisky; O Uhlenbeck; M Yarus
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

7.  Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.

Authors:  S Michalowski; J W Miller; C R Urbinati; M Paliouras; M S Swanson; J Griffith
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

8.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

9.  Regulation of alternative splicing of alpha-actinin transcript by Bruno-like proteins.

Authors:  Hitoshi Suzuki; Yui Jin; Hifumi Otani; Kunio Yasuda; Kunio Inoue
Journal:  Genes Cells       Date:  2002-02       Impact factor: 1.891

10.  The Drosophila Bruno paralogue Bru-3 specifically binds the EDEN translational repression element.

Authors:  Jérôme Delaunay; Gwenn Le Mée; Nader Ezzeddine; Gilles Labesse; Christophe Terzian; Michèle Capri; Ounissa Aït-Ahmed
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

View more
  54 in total

1.  Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing.

Authors:  Saikat Chakraborty; Shabana Mehtab; Anand Patwardhan; Yamuna Krishnan
Journal:  RNA       Date:  2012-03-26       Impact factor: 4.942

2.  Multiple RNA binding domains of Bruno confer recognition of diverse binding sites for translational repression.

Authors:  Brad Reveal; Carlos Garcia; Andrew Ellington; Paul M Macdonald
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

Review 3.  Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Curr Opin Genet Dev       Date:  2011-04-13       Impact factor: 5.578

4.  Spatially restricted translation of the xCR1 mRNA in Xenopus embryos.

Authors:  Yan Zhang; Kara D Forinash; Jered McGivern; Brian Fritz; Karel Dorey; Michael D Sheets
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 5.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

6.  High-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs.

Authors:  Brian Chang; J Levin; William A Thompson; William G Fairbrother
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

7.  Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells.

Authors:  Jerome E Lee; Ju Youn Lee; Jeffrey Wilusz; Bin Tian; Carol J Wilusz
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3.

Authors:  Kengo Tsuda; Kanako Kuwasako; Mari Takahashi; Tatsuhiko Someya; Makoto Inoue; Takaho Terada; Naohiro Kobayashi; Mikako Shirouzu; Takanori Kigawa; Akiko Tanaka; Sumio Sugano; Peter Güntert; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Nucleic Acids Res       Date:  2009-06-24       Impact factor: 16.971

9.  The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation.

Authors:  Victoria A Barron; Hui Zhu; Melissa N Hinman; Andrea N Ladd; Hua Lou
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

10.  Novel recognition motifs and biological functions of the RNA-binding protein HuD revealed by genome-wide identification of its targets.

Authors:  Federico Bolognani; Tania Contente-Cuomo; Nora I Perrone-Bizzozero
Journal:  Nucleic Acids Res       Date:  2009-10-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.